Ekso Bionics Holdings Inc (EKSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,021 | -5,600 | -2,891 | -11,330 | -7,917 |
| Depreciation Amortization | 1,122 | 755 | 378 | 1,608 | 1,210 |
| Accounts receivable | 1,545 | 3,052 | 900 | -1,967 | -1,427 |
| Accounts payable and accrued liabilities | 95 | -121 | 444 | -288 | -41 |
| Other Working Capital | -543 | 745 | 750 | -2,525 | -2,497 |
| Other Operating Activity | -2,668 | -4,240 | -1,546 | 4,656 | 2,259 |
| Operating Cash Flow | $-7,470 | $-5,409 | $-1,965 | $-9,846 | $-8,413 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -50 | -10 | N/A | -16 |
| Net Acquisitions | N/A | N/A | N/A | -37 | N/A |
| Investing Cash Flow | $-62 | $-50 | $-10 | $-37 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -938 | -625 | -313 | -1,250 | -938 |
| Common Stock Issued | 4,722 | 4,770 | 3,842 | 9,019 | 9,021 |
| Other Financing Activity | -76 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,708 | $4,145 | $3,529 | $7,769 | $8,083 |
| Exchange Rate Effect | 53 | 63 | 7 | -31 | N/A |
| Beginning Cash Position | 6,493 | 6,493 | 6,493 | 8,638 | 8,638 |
| End Cash Position | 2,722 | 5,242 | 8,054 | 6,493 | 8,292 |
| Net Cash Flow | $-3,771 | $-1,251 | $1,561 | $-2,145 | $-346 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,470 | -5,409 | -1,965 | -9,846 | -8,413 |
| Capital Expenditure | -62 | -50 | -10 | N/A | -16 |
| Free Cash Flow | -7,532 | -5,459 | -1,975 | -9,846 | -8,429 |